nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC2—type 2 diabetes mellitus	0.232	1	CbGaD
Lamivudine—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0529	0.129	CbGbCtD
Lamivudine—ABCC3—Glyburide—type 2 diabetes mellitus	0.0468	0.114	CbGbCtD
Lamivudine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0304	0.0739	CbGbCtD
Lamivudine—ABCC1—Glyburide—type 2 diabetes mellitus	0.0287	0.0699	CbGbCtD
Lamivudine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0271	0.0659	CbGbCtD
Lamivudine—SLC22A3—Metformin—type 2 diabetes mellitus	0.0266	0.0648	CbGbCtD
Lamivudine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.023	0.056	CbGbCtD
Lamivudine—ABCC2—Glyburide—type 2 diabetes mellitus	0.0213	0.0517	CbGbCtD
Lamivudine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.021	0.0511	CbGbCtD
Lamivudine—ABCG2—Glyburide—type 2 diabetes mellitus	0.0192	0.0468	CbGbCtD
Lamivudine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0187	0.0456	CbGbCtD
Lamivudine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0158	0.0384	CbGbCtD
Lamivudine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0156	0.0378	CbGbCtD
Lamivudine—SLC22A6—Losartan—type 2 diabetes mellitus	0.0142	0.0346	CbGbCtD
Lamivudine—SLC22A1—Metformin—type 2 diabetes mellitus	0.0137	0.0333	CbGbCtD
Lamivudine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0135	0.0329	CbGbCtD
Lamivudine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0093	0.0226	CbGbCtD
Lamivudine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00693	0.0169	CbGbCtD
Lamivudine—ABCB1—Losartan—type 2 diabetes mellitus	0.00634	0.0154	CbGbCtD
Lamivudine—PCYT2—kidney—type 2 diabetes mellitus	0.00246	0.0499	CbGeAlD
Lamivudine—NME1—Paromomycin—Acarbose—type 2 diabetes mellitus	0.00174	0.623	CbGdCrCtD
Lamivudine—Decitabine—DNMT1—type 2 diabetes mellitus	0.00172	0.807	CrCbGaD
Lamivudine—PCYT1A—cardiovascular system—type 2 diabetes mellitus	0.00171	0.0347	CbGeAlD
Lamivudine—NT5C—adipose tissue—type 2 diabetes mellitus	0.00161	0.0326	CbGeAlD
Lamivudine—PCYT2—liver—type 2 diabetes mellitus	0.00156	0.0316	CbGeAlD
Lamivudine—CMPK1—islet of Langerhans—type 2 diabetes mellitus	0.00153	0.031	CbGeAlD
Lamivudine—NME2—islet of Langerhans—type 2 diabetes mellitus	0.00149	0.0303	CbGeAlD
Lamivudine—PGK1—liver—type 2 diabetes mellitus	0.00134	0.0271	CbGeAlD
Lamivudine—NME2—retina—type 2 diabetes mellitus	0.00128	0.0259	CbGeAlD
Lamivudine—CMPK1—nephron tubule—type 2 diabetes mellitus	0.00123	0.0249	CbGeAlD
Lamivudine—NME1-NME2—liver—type 2 diabetes mellitus	0.00122	0.0247	CbGeAlD
Lamivudine—NME1—cardiovascular system—type 2 diabetes mellitus	0.00115	0.0232	CbGeAlD
Lamivudine—NT5C—liver—type 2 diabetes mellitus	0.00113	0.0229	CbGeAlD
Lamivudine—NME1—kidney—type 2 diabetes mellitus	0.00112	0.0227	CbGeAlD
Lamivudine—CMPK1—cardiovascular system—type 2 diabetes mellitus	0.0011	0.0224	CbGeAlD
Lamivudine—CMPK1—kidney—type 2 diabetes mellitus	0.00108	0.0219	CbGeAlD
Lamivudine—NME2—cardiovascular system—type 2 diabetes mellitus	0.00108	0.0219	CbGeAlD
Lamivudine—CMPK1—pancreas—type 2 diabetes mellitus	0.00107	0.0218	CbGeAlD
Lamivudine—PCYT1A—liver—type 2 diabetes mellitus	0.00106	0.0215	CbGeAlD
Lamivudine—NME1—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00105	0.377	CbGdCrCtD
Lamivudine—CMPK1—cortex of kidney—type 2 diabetes mellitus	0.00105	0.0213	CbGeAlD
Lamivudine—NME2—pancreas—type 2 diabetes mellitus	0.00105	0.0213	CbGeAlD
Lamivudine—NME1—adipose tissue—type 2 diabetes mellitus	0.00101	0.0205	CbGeAlD
Lamivudine—CMPK1—adipose tissue—type 2 diabetes mellitus	0.000974	0.0197	CbGeAlD
Lamivudine—NME2—adipose tissue—type 2 diabetes mellitus	0.000952	0.0193	CbGeAlD
Lamivudine—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000802	0.0163	CbGeAlD
Lamivudine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00076	0.0154	CbGeAlD
Lamivudine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000739	0.015	CbGeAlD
Lamivudine—NME1—liver—type 2 diabetes mellitus	0.000709	0.0144	CbGeAlD
Lamivudine—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000686	0.0139	CbGeAlD
Lamivudine—CMPK1—liver—type 2 diabetes mellitus	0.000683	0.0138	CbGeAlD
Lamivudine—NME2—liver—type 2 diabetes mellitus	0.000668	0.0135	CbGeAlD
Lamivudine—DCK—retina—type 2 diabetes mellitus	0.00065	0.0132	CbGeAlD
Lamivudine—SLC22A2—kidney—type 2 diabetes mellitus	0.00065	0.0132	CbGeAlD
Lamivudine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000633	0.0128	CbGeAlD
Lamivudine—DCK—nephron tubule—type 2 diabetes mellitus	0.000612	0.0124	CbGeAlD
Lamivudine—DCK—pancreas—type 2 diabetes mellitus	0.000535	0.0108	CbGeAlD
Lamivudine—DCK—cortex of kidney—type 2 diabetes mellitus	0.000524	0.0106	CbGeAlD
Lamivudine—ABCC3—kidney—type 2 diabetes mellitus	0.000515	0.0104	CbGeAlD
Lamivudine—DCK—adipose tissue—type 2 diabetes mellitus	0.000485	0.00983	CbGeAlD
Lamivudine—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000484	0.00981	CbGeAlD
Lamivudine—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000468	0.00949	CbGeAlD
Lamivudine—ABCC3—adipose tissue—type 2 diabetes mellitus	0.000464	0.00941	CbGeAlD
Lamivudine—SLC22A1—kidney—type 2 diabetes mellitus	0.000459	0.0093	CbGeAlD
Lamivudine—SLC22A3—kidney—type 2 diabetes mellitus	0.000439	0.00889	CbGeAlD
Lamivudine—ABCC4—kidney—type 2 diabetes mellitus	0.000425	0.00862	CbGeAlD
Lamivudine—ABCC4—pancreas—type 2 diabetes mellitus	0.000422	0.00856	CbGeAlD
Lamivudine—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000414	0.00839	CbGeAlD
Lamivudine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000414	0.00838	CbGeAlD
Lamivudine—ABCC2—kidney—type 2 diabetes mellitus	0.000412	0.00834	CbGeAlD
Lamivudine—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000401	0.00813	CbGeAlD
Lamivudine—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000395	0.00801	CbGeAlD
Lamivudine—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000383	0.00777	CbGeAlD
Lamivudine—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000353	0.00716	CbGeAlD
Lamivudine—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000342	0.00692	CbGeAlD
Lamivudine—DCK—liver—type 2 diabetes mellitus	0.00034	0.00689	CbGeAlD
Lamivudine—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000327	0.00662	CbGeAlD
Lamivudine—ABCC3—liver—type 2 diabetes mellitus	0.000326	0.0066	CbGeAlD
Lamivudine—SLC22A1—liver—type 2 diabetes mellitus	0.00029	0.00588	CbGeAlD
Lamivudine—SLC22A3—liver—type 2 diabetes mellitus	0.000277	0.00562	CbGeAlD
Lamivudine—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000271	0.00548	CbGeAlD
Lamivudine—ABCC4—liver—type 2 diabetes mellitus	0.000269	0.00545	CbGeAlD
Lamivudine—ABCC2—liver—type 2 diabetes mellitus	0.00026	0.00527	CbGeAlD
Lamivudine—Zalcitabine—CYP3A4—type 2 diabetes mellitus	0.000245	0.115	CrCbGaD
Lamivudine—ABCC1—liver—type 2 diabetes mellitus	0.000229	0.00465	CbGeAlD
Lamivudine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000209	0.00424	CbGeAlD
Lamivudine—ABCG2—liver—type 2 diabetes mellitus	0.00019	0.00385	CbGeAlD
Lamivudine—ABCB1—retina—type 2 diabetes mellitus	0.000179	0.00362	CbGeAlD
Lamivudine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000168	0.00341	CbGeAlD
Lamivudine—Cytarabine—CYP3A4—type 2 diabetes mellitus	0.000164	0.0773	CrCbGaD
Lamivudine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000151	0.00307	CbGeAlD
Lamivudine—ABCB1—kidney—type 2 diabetes mellitus	0.000148	0.003	CbGeAlD
Lamivudine—ABCB1—pancreas—type 2 diabetes mellitus	0.000147	0.00298	CbGeAlD
Lamivudine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000144	0.00292	CbGeAlD
Lamivudine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000133	0.0027	CbGeAlD
Lamivudine—ABCB1—liver—type 2 diabetes mellitus	9.36e-05	0.0019	CbGeAlD
Lamivudine—Myalgia—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000445	CcSEcCtD
Lamivudine—Shock—Metformin—type 2 diabetes mellitus	7.94e-05	0.000445	CcSEcCtD
Lamivudine—Insomnia—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000444	CcSEcCtD
Lamivudine—Malaise—Losartan—type 2 diabetes mellitus	7.92e-05	0.000444	CcSEcCtD
Lamivudine—Anxiety—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.000444	CcSEcCtD
Lamivudine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.92e-05	0.000443	CcSEcCtD
Lamivudine—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.92e-05	0.000443	CcSEcCtD
Lamivudine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.91e-05	0.000443	CcSEcCtD
Lamivudine—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000443	CcSEcCtD
Lamivudine—Vertigo—Losartan—type 2 diabetes mellitus	7.89e-05	0.000442	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000442	CcSEcCtD
Lamivudine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.000442	CcSEcCtD
Lamivudine—Somnolence—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000441	CcSEcCtD
Lamivudine—Syncope—Losartan—type 2 diabetes mellitus	7.88e-05	0.000441	CcSEcCtD
Lamivudine—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.87e-05	0.000441	CcSEcCtD
Lamivudine—Leukopenia—Losartan—type 2 diabetes mellitus	7.87e-05	0.00044	CcSEcCtD
Lamivudine—Discomfort—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.00044	CcSEcCtD
Lamivudine—Skin disorder—Metformin—type 2 diabetes mellitus	7.84e-05	0.000439	CcSEcCtD
Lamivudine—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000438	CcSEcCtD
Lamivudine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.81e-05	0.000437	CcSEcCtD
Lamivudine—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000437	CcSEcCtD
Lamivudine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000437	CcSEcCtD
Lamivudine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.78e-05	0.000435	CcSEcCtD
Lamivudine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000435	CcSEcCtD
Lamivudine—Nausea—Glimepiride—type 2 diabetes mellitus	7.74e-05	0.000433	CcSEcCtD
Lamivudine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.72e-05	0.000432	CcSEcCtD
Lamivudine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.72e-05	0.000432	CcSEcCtD
Lamivudine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000432	CcSEcCtD
Lamivudine—Asthenia—Glyburide—type 2 diabetes mellitus	7.71e-05	0.000432	CcSEcCtD
Lamivudine—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.71e-05	0.000432	CcSEcCtD
Lamivudine—Anorexia—Metformin—type 2 diabetes mellitus	7.7e-05	0.000431	CcSEcCtD
Lamivudine—Cough—Losartan—type 2 diabetes mellitus	7.67e-05	0.000429	CcSEcCtD
Lamivudine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.000429	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000429	CcSEcCtD
Lamivudine—Alopecia—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000428	CcSEcCtD
Lamivudine—Fatigue—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000428	CcSEcCtD
Lamivudine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000427	CcSEcCtD
Lamivudine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000427	CcSEcCtD
Lamivudine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000427	CcSEcCtD
Lamivudine—Oedema—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000427	CcSEcCtD
Lamivudine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000426	CcSEcCtD
Lamivudine—Pruritus—Glyburide—type 2 diabetes mellitus	7.6e-05	0.000426	CcSEcCtD
Lamivudine—Constipation—Valsartan—type 2 diabetes mellitus	7.58e-05	0.000425	CcSEcCtD
Lamivudine—Infection—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000424	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.56e-05	0.000424	CcSEcCtD
Lamivudine—Fatigue—Orlistat—type 2 diabetes mellitus	7.55e-05	0.000423	CcSEcCtD
Lamivudine—Hypotension—Metformin—type 2 diabetes mellitus	7.55e-05	0.000423	CcSEcCtD
Lamivudine—Erythema—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000422	CcSEcCtD
Lamivudine—Malnutrition—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000422	CcSEcCtD
Lamivudine—Shock—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.00042	CcSEcCtD
Lamivudine—Pain—Orlistat—type 2 diabetes mellitus	7.49e-05	0.00042	CcSEcCtD
Lamivudine—Arthralgia—Losartan—type 2 diabetes mellitus	7.48e-05	0.000419	CcSEcCtD
Lamivudine—Chest pain—Losartan—type 2 diabetes mellitus	7.48e-05	0.000419	CcSEcCtD
Lamivudine—Myalgia—Losartan—type 2 diabetes mellitus	7.48e-05	0.000419	CcSEcCtD
Lamivudine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.48e-05	0.000419	CcSEcCtD
Lamivudine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000418	CcSEcCtD
Lamivudine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000418	CcSEcCtD
Lamivudine—Anxiety—Losartan—type 2 diabetes mellitus	7.46e-05	0.000417	CcSEcCtD
Lamivudine—Rash—Bromocriptine—type 2 diabetes mellitus	7.41e-05	0.000415	CcSEcCtD
Lamivudine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.41e-05	0.000415	CcSEcCtD
Lamivudine—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000414	CcSEcCtD
Lamivudine—Tension—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000414	CcSEcCtD
Lamivudine—Discomfort—Losartan—type 2 diabetes mellitus	7.39e-05	0.000414	CcSEcCtD
Lamivudine—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000413	CcSEcCtD
Lamivudine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000412	CcSEcCtD
Lamivudine—Headache—Bromocriptine—type 2 diabetes mellitus	7.37e-05	0.000412	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.36e-05	0.000412	CcSEcCtD
Lamivudine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.35e-05	0.000412	CcSEcCtD
Lamivudine—Nervousness—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00041	CcSEcCtD
Lamivudine—Dry mouth—Losartan—type 2 diabetes mellitus	7.32e-05	0.00041	CcSEcCtD
Lamivudine—Anorexia—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000407	CcSEcCtD
Lamivudine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000406	CcSEcCtD
Lamivudine—Paraesthesia—Metformin—type 2 diabetes mellitus	7.25e-05	0.000406	CcSEcCtD
Lamivudine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000406	CcSEcCtD
Lamivudine—Confusional state—Losartan—type 2 diabetes mellitus	7.23e-05	0.000405	CcSEcCtD
Lamivudine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000404	CcSEcCtD
Lamivudine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.2e-05	0.000403	CcSEcCtD
Lamivudine—Somnolence—Metformin—type 2 diabetes mellitus	7.18e-05	0.000402	CcSEcCtD
Lamivudine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.17e-05	0.000402	CcSEcCtD
Lamivudine—Oedema—Losartan—type 2 diabetes mellitus	7.17e-05	0.000402	CcSEcCtD
Lamivudine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000401	CcSEcCtD
Lamivudine—Infection—Losartan—type 2 diabetes mellitus	7.12e-05	0.000399	CcSEcCtD
Lamivudine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000399	CcSEcCtD
Lamivudine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.11e-05	0.000398	CcSEcCtD
Lamivudine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.11e-05	0.000398	CcSEcCtD
Lamivudine—Tremor—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000395	CcSEcCtD
Lamivudine—Shock—Losartan—type 2 diabetes mellitus	7.06e-05	0.000395	CcSEcCtD
Lamivudine—Urticaria—Valsartan—type 2 diabetes mellitus	7.04e-05	0.000394	CcSEcCtD
Lamivudine—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.03e-05	0.000394	CcSEcCtD
Lamivudine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.02e-05	0.000393	CcSEcCtD
Lamivudine—Decreased appetite—Metformin—type 2 diabetes mellitus	7.02e-05	0.000393	CcSEcCtD
Lamivudine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000393	CcSEcCtD
Lamivudine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000391	CcSEcCtD
Lamivudine—Nausea—Bromocriptine—type 2 diabetes mellitus	6.98e-05	0.000391	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.97e-05	0.00039	CcSEcCtD
Lamivudine—Fatigue—Metformin—type 2 diabetes mellitus	6.96e-05	0.00039	CcSEcCtD
Lamivudine—Urticaria—Orlistat—type 2 diabetes mellitus	6.96e-05	0.00039	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000389	CcSEcCtD
Lamivudine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.93e-05	0.000388	CcSEcCtD
Lamivudine—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.93e-05	0.000388	CcSEcCtD
Lamivudine—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.93e-05	0.000388	CcSEcCtD
Lamivudine—Asthenia—Gliclazide—type 2 diabetes mellitus	6.92e-05	0.000388	CcSEcCtD
Lamivudine—Constipation—Metformin—type 2 diabetes mellitus	6.91e-05	0.000387	CcSEcCtD
Lamivudine—Angioedema—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000386	CcSEcCtD
Lamivudine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000383	CcSEcCtD
Lamivudine—Anorexia—Losartan—type 2 diabetes mellitus	6.84e-05	0.000383	CcSEcCtD
Lamivudine—Vomiting—Glyburide—type 2 diabetes mellitus	6.83e-05	0.000383	CcSEcCtD
Lamivudine—Pruritus—Gliclazide—type 2 diabetes mellitus	6.83e-05	0.000382	CcSEcCtD
Lamivudine—Malaise—Ramipril—type 2 diabetes mellitus	6.79e-05	0.00038	CcSEcCtD
Lamivudine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.00038	CcSEcCtD
Lamivudine—Rash—Glyburide—type 2 diabetes mellitus	6.78e-05	0.000379	CcSEcCtD
Lamivudine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000379	CcSEcCtD
Lamivudine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.77e-05	0.000379	CcSEcCtD
Lamivudine—Vertigo—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000379	CcSEcCtD
Lamivudine—Syncope—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000378	CcSEcCtD
Lamivudine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000378	CcSEcCtD
Lamivudine—Headache—Glyburide—type 2 diabetes mellitus	6.73e-05	0.000377	CcSEcCtD
Lamivudine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000376	CcSEcCtD
Lamivudine—Hypotension—Losartan—type 2 diabetes mellitus	6.7e-05	0.000375	CcSEcCtD
Lamivudine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.65e-05	0.000373	CcSEcCtD
Lamivudine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000371	CcSEcCtD
Lamivudine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000371	CcSEcCtD
Lamivudine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.6e-05	0.00037	CcSEcCtD
Lamivudine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.6e-05	0.00037	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000368	CcSEcCtD
Lamivudine—Cough—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000368	CcSEcCtD
Lamivudine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000368	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.53e-05	0.000366	CcSEcCtD
Lamivudine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.53e-05	0.000366	CcSEcCtD
Lamivudine—Convulsion—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000366	CcSEcCtD
Lamivudine—Pain—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000365	CcSEcCtD
Lamivudine—Constipation—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000365	CcSEcCtD
Lamivudine—Insomnia—Losartan—type 2 diabetes mellitus	6.49e-05	0.000363	CcSEcCtD
Lamivudine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.46e-05	0.000361	CcSEcCtD
Lamivudine—Paraesthesia—Losartan—type 2 diabetes mellitus	6.44e-05	0.000361	CcSEcCtD
Lamivudine—Urticaria—Metformin—type 2 diabetes mellitus	6.41e-05	0.000359	CcSEcCtD
Lamivudine—Chest pain—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000359	CcSEcCtD
Lamivudine—Myalgia—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000359	CcSEcCtD
Lamivudine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000359	CcSEcCtD
Lamivudine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.39e-05	0.000358	CcSEcCtD
Lamivudine—Anxiety—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000358	CcSEcCtD
Lamivudine—Nausea—Glyburide—type 2 diabetes mellitus	6.38e-05	0.000357	CcSEcCtD
Lamivudine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.38e-05	0.000357	CcSEcCtD
Lamivudine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.38e-05	0.000357	CcSEcCtD
Lamivudine—Somnolence—Losartan—type 2 diabetes mellitus	6.38e-05	0.000357	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000357	CcSEcCtD
Lamivudine—Asthenia—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000356	CcSEcCtD
Lamivudine—Discomfort—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000355	CcSEcCtD
Lamivudine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.31e-05	0.000353	CcSEcCtD
Lamivudine—Asthenia—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000352	CcSEcCtD
Lamivudine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000352	CcSEcCtD
Lamivudine—Pruritus—Valsartan—type 2 diabetes mellitus	6.27e-05	0.000351	CcSEcCtD
Lamivudine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000351	CcSEcCtD
Lamivudine—Decreased appetite—Losartan—type 2 diabetes mellitus	6.23e-05	0.000349	CcSEcCtD
Lamivudine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000349	CcSEcCtD
Lamivudine—Confusional state—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000347	CcSEcCtD
Lamivudine—Pruritus—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000347	CcSEcCtD
Lamivudine—Fatigue—Losartan—type 2 diabetes mellitus	6.18e-05	0.000346	CcSEcCtD
Lamivudine—Oedema—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000344	CcSEcCtD
Lamivudine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000344	CcSEcCtD
Lamivudine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000344	CcSEcCtD
Lamivudine—Constipation—Losartan—type 2 diabetes mellitus	6.13e-05	0.000343	CcSEcCtD
Lamivudine—Pain—Losartan—type 2 diabetes mellitus	6.13e-05	0.000343	CcSEcCtD
Lamivudine—Rash—Gliclazide—type 2 diabetes mellitus	6.09e-05	0.000341	CcSEcCtD
Lamivudine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.08e-05	0.00034	CcSEcCtD
Lamivudine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.07e-05	0.00034	CcSEcCtD
Lamivudine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.000339	CcSEcCtD
Lamivudine—Shock—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000339	CcSEcCtD
Lamivudine—Headache—Gliclazide—type 2 diabetes mellitus	6.05e-05	0.000339	CcSEcCtD
Lamivudine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000338	CcSEcCtD
Lamivudine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000337	CcSEcCtD
Lamivudine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000337	CcSEcCtD
Lamivudine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000337	CcSEcCtD
Lamivudine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6e-05	0.000336	CcSEcCtD
Lamivudine—Skin disorder—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000334	CcSEcCtD
Lamivudine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000333	CcSEcCtD
Lamivudine—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.91e-05	0.000331	CcSEcCtD
Lamivudine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.86e-05	0.000328	CcSEcCtD
Lamivudine—Dizziness—Valsartan—type 2 diabetes mellitus	5.86e-05	0.000328	CcSEcCtD
Lamivudine—Anorexia—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000328	CcSEcCtD
Lamivudine—Dizziness—Orlistat—type 2 diabetes mellitus	5.79e-05	0.000324	CcSEcCtD
Lamivudine—Asthenia—Metformin—type 2 diabetes mellitus	5.79e-05	0.000324	CcSEcCtD
Lamivudine—Hypotension—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000322	CcSEcCtD
Lamivudine—Nausea—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000321	CcSEcCtD
Lamivudine—Pruritus—Metformin—type 2 diabetes mellitus	5.71e-05	0.00032	CcSEcCtD
Lamivudine—Urticaria—Losartan—type 2 diabetes mellitus	5.7e-05	0.000319	CcSEcCtD
Lamivudine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.67e-05	0.000317	CcSEcCtD
Lamivudine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.67e-05	0.000317	CcSEcCtD
Lamivudine—Vomiting—Valsartan—type 2 diabetes mellitus	5.64e-05	0.000316	CcSEcCtD
Lamivudine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000314	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000314	CcSEcCtD
Lamivudine—Rash—Valsartan—type 2 diabetes mellitus	5.59e-05	0.000313	CcSEcCtD
Lamivudine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.59e-05	0.000313	CcSEcCtD
Lamivudine—Vomiting—Orlistat—type 2 diabetes mellitus	5.57e-05	0.000312	CcSEcCtD
Lamivudine—Insomnia—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000311	CcSEcCtD
Lamivudine—Headache—Valsartan—type 2 diabetes mellitus	5.56e-05	0.000311	CcSEcCtD
Lamivudine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.52e-05	0.000309	CcSEcCtD
Lamivudine—Rash—Orlistat—type 2 diabetes mellitus	5.52e-05	0.000309	CcSEcCtD
Lamivudine—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000309	CcSEcCtD
Lamivudine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.52e-05	0.000309	CcSEcCtD
Lamivudine—Headache—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000307	CcSEcCtD
Lamivudine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000307	CcSEcCtD
Lamivudine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000306	CcSEcCtD
Lamivudine—Somnolence—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000306	CcSEcCtD
Lamivudine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000303	CcSEcCtD
Lamivudine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.39e-05	0.000302	CcSEcCtD
Lamivudine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000299	CcSEcCtD
Lamivudine—Dizziness—Metformin—type 2 diabetes mellitus	5.34e-05	0.000299	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000297	CcSEcCtD
Lamivudine—Fatigue—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000297	CcSEcCtD
Lamivudine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.28e-05	0.000296	CcSEcCtD
Lamivudine—Nausea—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000295	CcSEcCtD
Lamivudine—Constipation—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000294	CcSEcCtD
Lamivudine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000292	CcSEcCtD
Lamivudine—Nausea—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000291	CcSEcCtD
Lamivudine—Asthenia—Losartan—type 2 diabetes mellitus	5.15e-05	0.000288	CcSEcCtD
Lamivudine—Vomiting—Metformin—type 2 diabetes mellitus	5.13e-05	0.000287	CcSEcCtD
Lamivudine—Rash—Metformin—type 2 diabetes mellitus	5.09e-05	0.000285	CcSEcCtD
Lamivudine—Dermatitis—Metformin—type 2 diabetes mellitus	5.09e-05	0.000285	CcSEcCtD
Lamivudine—Pruritus—Losartan—type 2 diabetes mellitus	5.07e-05	0.000284	CcSEcCtD
Lamivudine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000284	CcSEcCtD
Lamivudine—Headache—Metformin—type 2 diabetes mellitus	5.06e-05	0.000283	CcSEcCtD
Lamivudine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000282	CcSEcCtD
Lamivudine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000282	CcSEcCtD
Lamivudine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.91e-05	0.000275	CcSEcCtD
Lamivudine—Urticaria—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000274	CcSEcCtD
Lamivudine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000272	CcSEcCtD
Lamivudine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000272	CcSEcCtD
Lamivudine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000271	CcSEcCtD
Lamivudine—Rash—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000269	CcSEcCtD
Lamivudine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000269	CcSEcCtD
Lamivudine—Nausea—Metformin—type 2 diabetes mellitus	4.8e-05	0.000269	CcSEcCtD
Lamivudine—Headache—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000267	CcSEcCtD
Lamivudine—Dizziness—Losartan—type 2 diabetes mellitus	4.74e-05	0.000266	CcSEcCtD
Lamivudine—Vomiting—Losartan—type 2 diabetes mellitus	4.56e-05	0.000255	CcSEcCtD
Lamivudine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000254	CcSEcCtD
Lamivudine—Nausea—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000253	CcSEcCtD
Lamivudine—Rash—Losartan—type 2 diabetes mellitus	4.52e-05	0.000253	CcSEcCtD
Lamivudine—Dermatitis—Losartan—type 2 diabetes mellitus	4.52e-05	0.000253	CcSEcCtD
Lamivudine—Headache—Losartan—type 2 diabetes mellitus	4.49e-05	0.000252	CcSEcCtD
Lamivudine—Asthenia—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000247	CcSEcCtD
Lamivudine—Pruritus—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000244	CcSEcCtD
Lamivudine—Nausea—Losartan—type 2 diabetes mellitus	4.26e-05	0.000239	CcSEcCtD
Lamivudine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000236	CcSEcCtD
Lamivudine—Dizziness—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000228	CcSEcCtD
Lamivudine—Vomiting—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000219	CcSEcCtD
Lamivudine—Rash—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000217	CcSEcCtD
Lamivudine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000217	CcSEcCtD
Lamivudine—Headache—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000216	CcSEcCtD
Lamivudine—Nausea—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000205	CcSEcCtD
Lamivudine—NME2—Metabolism—AKT1—type 2 diabetes mellitus	5.4e-06	4.35e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.4e-06	4.35e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.39e-06	4.34e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CD36—type 2 diabetes mellitus	5.36e-06	4.32e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPP2CA—type 2 diabetes mellitus	5.3e-06	4.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	5.28e-06	4.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	5.28e-06	4.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—LPL—type 2 diabetes mellitus	5.28e-06	4.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	5.28e-06	4.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	5.28e-06	4.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	5.28e-06	4.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	5.26e-06	4.24e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGT—type 2 diabetes mellitus	5.25e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.23e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	5.19e-06	4.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	5.18e-06	4.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.18e-06	4.17e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.17e-06	4.17e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A2—type 2 diabetes mellitus	5.17e-06	4.17e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ADCY5—type 2 diabetes mellitus	5.17e-06	4.17e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CALM1—type 2 diabetes mellitus	5.17e-06	4.16e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—type 2 diabetes mellitus	5.15e-06	4.15e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	5.13e-06	4.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	5.12e-06	4.13e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.12e-06	4.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.12e-06	4.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	5.1e-06	4.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	5.1e-06	4.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	5.1e-06	4.11e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOA1—type 2 diabetes mellitus	5.09e-06	4.1e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—type 2 diabetes mellitus	5.08e-06	4.1e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.04e-06	4.07e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.03e-06	4.06e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.02e-06	4.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.99e-06	4.02e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARA—type 2 diabetes mellitus	4.99e-06	4.02e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.96e-06	4e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GCG—type 2 diabetes mellitus	4.96e-06	4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PPP2CA—type 2 diabetes mellitus	4.95e-06	3.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.93e-06	3.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.91e-06	3.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.91e-06	3.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	4.91e-06	3.96e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.87e-06	3.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CCR5—type 2 diabetes mellitus	4.87e-06	3.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.86e-06	3.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNB3—type 2 diabetes mellitus	4.86e-06	3.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—type 2 diabetes mellitus	4.84e-06	3.9e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGT—type 2 diabetes mellitus	4.83e-06	3.89e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.83e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	4.8e-06	3.87e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.77e-06	3.85e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.77e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAT—type 2 diabetes mellitus	4.77e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	4.75e-06	3.83e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CALM1—type 2 diabetes mellitus	4.75e-06	3.83e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—type 2 diabetes mellitus	4.73e-06	3.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.7e-06	3.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.7e-06	3.79e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOA1—type 2 diabetes mellitus	4.68e-06	3.77e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.65e-06	3.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	4.63e-06	3.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.61e-06	3.71e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.57e-06	3.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	4.57e-06	3.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	4.53e-06	3.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS2—type 2 diabetes mellitus	4.52e-06	3.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	4.51e-06	3.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	4.49e-06	3.62e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—type 2 diabetes mellitus	4.48e-06	3.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CALM1—type 2 diabetes mellitus	4.44e-06	3.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—type 2 diabetes mellitus	4.43e-06	3.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	4.42e-06	3.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.4e-06	3.54e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—INS—type 2 diabetes mellitus	4.4e-06	3.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.39e-06	3.54e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOA1—type 2 diabetes mellitus	4.38e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	4.34e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	4.34e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	4.34e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	4.34e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	4.33e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	4.31e-06	3.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.27e-06	3.45e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	4.27e-06	3.45e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	4.25e-06	3.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	4.23e-06	3.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.23e-06	3.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.21e-06	3.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	4.2e-06	3.39e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	4.2e-06	3.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	4.16e-06	3.35e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	4.15e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.15e-06	3.34e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—type 2 diabetes mellitus	4.12e-06	3.32e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—type 2 diabetes mellitus	4.12e-06	3.32e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—type 2 diabetes mellitus	4.09e-06	3.3e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	4.08e-06	3.28e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—INS—type 2 diabetes mellitus	4.04e-06	3.26e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	4.03e-06	3.25e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—type 2 diabetes mellitus	4.03e-06	3.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	3.98e-06	3.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.97e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	3.96e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS1—type 2 diabetes mellitus	3.95e-06	3.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	3.94e-06	3.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.94e-06	3.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	3.92e-06	3.16e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.92e-06	3.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	3.91e-06	3.15e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	3.89e-06	3.14e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	3.87e-06	3.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	3.87e-06	3.12e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3R1—type 2 diabetes mellitus	3.86e-06	3.11e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—type 2 diabetes mellitus	3.86e-06	3.11e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	3.85e-06	3.1e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	3.81e-06	3.07e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	3.8e-06	3.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	3.78e-06	3.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—INS—type 2 diabetes mellitus	3.78e-06	3.05e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	3.78e-06	3.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.77e-06	3.04e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	3.76e-06	3.03e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	3.76e-06	3.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.72e-06	3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	3.72e-06	3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	3.71e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—type 2 diabetes mellitus	3.71e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	3.7e-06	2.98e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	3.66e-06	2.95e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	3.66e-06	2.95e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.66e-06	2.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT2—type 2 diabetes mellitus	3.65e-06	2.95e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.65e-06	2.94e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.61e-06	2.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.61e-06	2.91e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	3.59e-06	2.89e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3R1—type 2 diabetes mellitus	3.54e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—type 2 diabetes mellitus	3.54e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	3.54e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	3.54e-06	2.85e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—type 2 diabetes mellitus	3.53e-06	2.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.51e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	3.5e-06	2.82e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	3.5e-06	2.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	3.47e-06	2.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	3.47e-06	2.8e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.47e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	3.45e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	3.45e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	3.45e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	3.44e-06	2.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.43e-06	2.76e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	3.41e-06	2.75e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	3.4e-06	2.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.37e-06	2.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.37e-06	2.71e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	3.33e-06	2.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3.33e-06	2.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	3.32e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—type 2 diabetes mellitus	3.32e-06	2.67e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	3.29e-06	2.66e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	3.27e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.27e-06	2.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	3.26e-06	2.63e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	3.24e-06	2.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	3.24e-06	2.61e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.23e-06	2.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	3.23e-06	2.6e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	3.23e-06	2.6e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	3.22e-06	2.6e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	3.19e-06	2.57e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	3.17e-06	2.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—INS—type 2 diabetes mellitus	3.17e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	3.09e-06	2.49e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	3.09e-06	2.49e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	3.09e-06	2.49e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	3.07e-06	2.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	3.04e-06	2.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	3.03e-06	2.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	3.02e-06	2.43e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	3.01e-06	2.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	3.01e-06	2.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	2.97e-06	2.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.95e-06	2.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.94e-06	2.37e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	2.9e-06	2.34e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	2.84e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.83e-06	2.28e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.81e-06	2.27e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	2.81e-06	2.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.8e-06	2.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.8e-06	2.25e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—INS—type 2 diabetes mellitus	2.79e-06	2.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	2.78e-06	2.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.78e-06	2.24e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	2.76e-06	2.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.73e-06	2.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.68e-06	2.16e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.68e-06	2.16e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	2.62e-06	2.11e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	2.57e-06	2.07e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.55e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	2.54e-06	2.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	2.53e-06	2.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—type 2 diabetes mellitus	2.45e-06	1.98e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.44e-06	1.97e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.44e-06	1.97e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.42e-06	1.95e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.42e-06	1.95e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	2.36e-06	1.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.31e-06	1.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.31e-06	1.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.3e-06	1.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.27e-06	1.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	1.82e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	1.82e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.24e-06	1.8e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.21e-06	1.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.2e-06	1.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.19e-06	1.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2.15e-06	1.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.14e-06	1.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.1e-06	1.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	1.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.06e-06	1.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.05e-06	1.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2e-06	1.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.97e-06	1.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.89e-06	1.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.86e-06	1.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.8e-06	1.45e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.77e-06	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.77e-06	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.76e-06	1.42e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.74e-06	1.41e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.65e-06	1.33e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-06	1.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	1.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.52e-06	1.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	1.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.38e-06	1.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.32e-06	1.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.32e-06	1.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-06	1.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	9.74e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-06	9.05e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	8.96e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	8.35e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.07e-07	4.9e-06	CbGpPWpGaD
